The combination of aspirin and ticagrelor (P2Y12) is associated with a higher risk of SCAD recurrence, with a 1.8-fold increase in the risk of MACE, whereas this risk is not observed with clopidogrel [6]. The gene discussed is P2RY12; the disease is spontaneous coronary artery dissection.